Blog list

AR technology is helping adults with amblyopia where traditional treatments couldn't—discover how enhanced training can reinvigorate vision.

Discover how retinal scans, interpreted by AI, can help detect serious systemic diseases early—ushering in a new era of preventive eye-centered healthcare.

VIZZ becomes the first aceclidine-based eye drop approved for presbyopia, promising near-vision clarity without glasses for up to 10 hours. Discover how it works and why it's a game-changer.

New AR and robotic tools are transforming oculoplastic surgery. Learn how real-time imaging and robotic guidance are improving safety and outcomes in eyelid and orbital procedures.

In 2025, Encelto became the first approved gene therapy implant for MacTel Type 2, offering a pioneering, one-time treatment to safeguard central vision in this rare retinal disease.

Fumagillin—a fungal-derived topical antibiotic—has treated a rare corneal infection without surgery in pilot cases, offering hope for less invasive eye care options.

Virtual eye models created with AI and imaging could transform vision therapy by predicting outcomes on a digital twin before real-world intervention.

Tiny and targeted—ocular microneedles are emerging as game-changing tools for treating eye diseases, delivering drugs more effectively and comfortably than ever before.

Clinics are moving toward stand-up eye exam stations to boost efficiency, reduce contact points, and support hybrid and telehealth models. Learn why this trend is gaining steam.

Tears aren’t just for emotion—they’re emerging as non-invasive test samples for eye disease and broader health issues. Explore this innovative diagnostic frontier.